- Home
- GKOS vs TPG Comparison
GKOS vs TPG Comparison
Compare GKOS & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GKOS
- TPG
- Stock Information
- Founded
- GKOS 1998
- TPG 1992
- Country
- GKOS United States
- TPG United States
- Employees
- GKOS N/A
- TPG N/A
- Industry
- GKOS Medical/Dental Instruments
- TPG Investment Managers
- Sector
- GKOS Health Care
- TPG Finance
- Exchange
- GKOS Nasdaq
- TPG Nasdaq
- Market Cap
- GKOS 8.4B
- TPG 7.0B
- IPO Year
- GKOS 2015
- TPG 2022
- Fundamental
- Price
- GKOS $156.36
- TPG $67.03
- Analyst Decision
- GKOS Strong Buy
- TPG Buy
- Analyst Count
- GKOS 13
- TPG 13
- Target Price
- GKOS $147.23
- TPG $60.75
- AVG Volume (30 Days)
- GKOS 662.3K
- TPG 952.8K
- Earning Date
- GKOS 02-19-2025
- TPG 02-11-2025
- Dividend Yield
- GKOS N/A
- TPG 2.27%
- EPS Growth
- GKOS N/A
- TPG N/A
- EPS
- GKOS N/A
- TPG N/A
- Revenue
- GKOS $360,347,000.00
- TPG $3,406,805,000.00
- Revenue This Year
- GKOS $22.69
- TPG N/A
- Revenue Next Year
- GKOS $26.76
- TPG $16.57
- P/E Ratio
- GKOS N/A
- TPG $2,777.14
- Revenue Growth
- GKOS 18.70
- TPG 84.54
- 52 Week Low
- GKOS $83.90
- TPG $39.16
- 52 Week High
- GKOS $161.13
- TPG $72.98
- Technical
- Relative Strength Index (RSI)
- GKOS 60.10
- TPG 55.66
- Support Level
- GKOS $142.71
- TPG $61.13
- Resistance Level
- GKOS $158.01
- TPG $66.61
- Average True Range (ATR)
- GKOS 4.96
- TPG 1.74
- MACD
- GKOS -0.16
- TPG 0.34
- Stochastic Oscillator
- GKOS 74.10
- TPG 97.52
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
About TPG TPG Inc.
TPG Inc is an alternative asset firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. TPG aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment and performance of its portfolio.